4B8-14184-39460
2 vaccinations
5 coded responses
21 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 860 / AZ
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 1 — Moderna
- 2021-01-21
- 2021-01-22
-
2021-01-23
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · Site: Itching · HeadacheFree text: DizzyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
- 2021-01-28
-
2021-02-18
Dose 2 — Moderna
-
2021-02-18
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-19
Survey response — days 1–6 daily, dose 2MedDRA: Paraesthesia, Paraesthesia oral — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Tingling in hands, feet and lipsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-27
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
-
2021-05-20
Survey response — 3 months, dose 2MedDRA: Urticaria — Feeling: GoodFree text: Frequent hives (nearly every day for the past 3 weeks) no known cause.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-24
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: GoodFree text: I had a common cold a couple weeks ago (tested negative for COVID) and it resolved within a few day.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-18
Survey response — 12 months, dose 2MedDRA: COVID-19, Cough, Fatigue, Headache, Heart rate increased, Oxygen saturation decreased, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Got COVID for about 10 days, high heart rate, low O2 levels, headache, fatigue congestion and a persistent cough. Tested negative about 2 weeks ago, cough/fatigue remain and heart rate occasionally spikes.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Moderna | |
| 2 | 2021-02-18 | Moderna |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Dizzy
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Tingling in hands, feet and lips
Release 8 — 3 months, dose 2
Symptoms: Frequent hives (nearly every day for the past 3 weeks) no known cause.
Release 9 — 6 months, dose 2
Symptoms: I had a common cold a couple weeks ago (tested negative for COVID) and it resolved within a few day.
Release 11 — 12 months, dose 2
Symptoms: Got COVID for about 10 days, high heart rate, low O2 levels, headache, fatigue congestion and a persistent cough. Tested negative about 2 weeks ago, cough/fatigue remain and heart rate occasionally spikes.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Oxygen saturation decreased | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Paraesthesia oral | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release